VectivBio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch VectivBio and buy or sell other stocks, ETFs, and their options commission-free!About VECT
VectivBio Holding AG is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of treatments for severe rare conditions with significant unmet medical need. It operates through Switzerland, Canada, and the United States geographical segment.
CEOLuca Santarelli, MD, PhD
CEOLuca Santarelli, MD, PhD
Employees—
Employees—
HeadquartersBasel, Basel-Stadt (Basle Town)
HeadquartersBasel, Basel-Stadt (Basle Town)
Founded2019
Founded2019
Employees—
Employees—
VECT Key Statistics
Market cap1.06B
Market cap1.06B
Price-Earnings ratio-7.93
Price-Earnings ratio-7.93
Dividend yield—
Dividend yield—
Average volume272.17K
Average volume272.17K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$16.98
52 Week high$16.98
52 Week low$4.25
52 Week low$4.25
Stock Snapshot
As of today, VectivBio(VECT) shares are valued at $16.85. The company's market cap stands at 1.06B, with a P/E ratio of -7.93.
On 2025-12-15, VectivBio(VECT) stock opened at —, reached a high of —, and a low of —.
The VectivBio(VECT)'s current trading volume is 0, compared to an average daily volume of 272.17K.
During the past year, VectivBio(VECT) stock moved between $4.25 at its lowest and $16.98 at its peak.
During the past year, VectivBio(VECT) stock moved between $4.25 at its lowest and $16.98 at its peak.
People also own
Based on the portfolios of people who own VECT. This list is generated using Robinhood data, and it’s not a recommendation.